These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31622740)

  • 41. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial.
    Sadrin S; Sennoune S; Gout B; Marque S; Moreau J; Zinoune K; Grillasca JP; Pons O; Maixent JM
    Dig Liver Dis; 2020 May; 52(5):534-540. PubMed ID: 31952938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
    Clavé P; Acalovschi M; Triantafillidis JK; Uspensky YP; Kalayci C; Shee V; Tack J;
    Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial.
    Basnayake C; Kamm MA; Stanley A; Wilson-O'Brien A; Burrell K; Lees-Trinca I; Khera A; Kantidakis J; Wong O; Fox K; Talley NJ; Liew D; Salzberg MR; Thompson AJ
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):890-899. PubMed ID: 32679040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study.
    Wittmann T; Paradowski L; Ducrotté P; Bueno L; Andro Delestrain MC
    Aliment Pharmacol Ther; 2010 Mar; 31(6):615-24. PubMed ID: 20003095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.
    Quigley EM; Tack J; Chey WD; Rao SS; Fortea J; Falques M; Diaz C; Shiff SJ; Currie MG; Johnston JM
    Aliment Pharmacol Ther; 2013 Jan; 37(1):49-61. PubMed ID: 23116208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
    Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
    Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial.
    Pace F; Maurano A; Ciacci C; Savarino V; Attili A; Iaquinto G; Magni E; Porro GB
    Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):155-62. PubMed ID: 20391952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, controlled, crossover study of sacral nerve stimulation for irritable bowel syndrome.
    Fassov JL; Lundby L; Laurberg S; Buntzen S; Krogh K
    Ann Surg; 2014 Jul; 260(1):31-6. PubMed ID: 24509204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial.
    Bauserman M; Michail S
    J Pediatr; 2005 Aug; 147(2):197-201. PubMed ID: 16126049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iyengar yoga for adolescents and young adults with irritable bowel syndrome.
    Evans S; Lung KC; Seidman LC; Sternlieb B; Zeltzer LK; Tsao JC
    J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):244-53. PubMed ID: 25025601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
    Mangel AW; Bornstein JD; Hamm LR; Buda J; Wang J; Irish W; Urso D
    Aliment Pharmacol Ther; 2008 Jul; 28(2):239-49. PubMed ID: 18466359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sacral nerve modulation for irritable bowel syndrome: A randomized, double-blinded, placebo-controlled crossover study.
    Fassov J; Lundby L; Laurberg S; Krogh K
    Neurogastroenterol Motil; 2019 Jun; 31(6):e13570. PubMed ID: 30793441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial.
    Hunt M; Miguez S; Dukas B; Onwude O; White S
    JMIR Mhealth Uhealth; 2021 May; 9(5):e26152. PubMed ID: 33872182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
    Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
    Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
    Videlock EJ; Cheng V; Cremonini F
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Symptom Profiles in Patients With Irritable Bowel Syndrome or Functional Abdominal Pain Compared With Healthy Controls.
    Varni JW; Shulman RJ; Self MM; Nurko S; Saps M; Saeed SA; Bendo CB; Patel AS; Dark CV; Zacur GM; Pohl JF;
    J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):323-9. PubMed ID: 26020482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and Safety of New
    Oh JH; Jang YS; Kang D; Chang DK; Min YW
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31783597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.
    Johnsen PH; Hilpüsch F; Cavanagh JP; Leikanger IS; Kolstad C; Valle PC; Goll R
    Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):17-24. PubMed ID: 29100842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
    Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
    BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.